Share on
A case of medicine in disguise: motion sickness patches sold as medical devices containing active pharmaceutical substances
Abstract
Introduction. A case study is reported on anti-motion sickness transdermal patches sold in the Internet, claiming to contain only natural ingredients but, actually, containing The visual inspection of the samples evidenced many inconsistencies in secondary and primary packaging, missing of various legal information and a non-compliant “CE” mark.
Methods. The qualitative analysis was performed by liquid chromatography - high resolution mass spectrometry and the quantitative by liquid chromatography with diode array detector.
Results. The analyses evidenced the presence of the antihistaminic drug Diphenhydramine and of other active substances (Capsaicin, a transdermal absorption enhancer, and Diclofenac in traces, probably a contaminant from other productions of the same plant). Moreover, the presence of several trace elements, including those potentially toxic to humans, was assessed by ICP-MS analysis.
Conclusions. The case discussed is a new case of “medicines in disguise” never reported
in literature, and shows the presence of tangible risks for public health.
Downloads
PDF
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright
Copyright (c) 2022 Istituto Superiore di Sanità
How to Cite
Gaudiano, M. C., Bertocchi, P., De Orsi, D., Manna, L., Antoniella, E., Rodomonte, A., Sorbo, A., Aureli, F., & Bartolomei, M. (2022). A case of medicine in disguise: motion sickness patches sold as medical devices containing active pharmaceutical substances. Annali dell’Istituto Superiore Di Sanità, 58(4), 254–263. Retrieved from https://annali.iss.it/index.php/anna/article/view/1508
- Abstract viewed - 402 times
- PDF downloaded - 145 times